Long-Term Results of Gastric Bypass Surgery in Morbidly Obese Type 1 Diabetes Patients
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Long-term effects of bariatric surgery in morbidly obese type 1 patients are unknown. Five to eight-year experience in the case series of type 1 diabetes subjects is presented.
Three poorly controlled type 1 diabetes patients, aged 19, 23, and 28 underwent Roux-en-Y gastric bypass surgery.
Their maximum body weight reduction noted during the follow-up was between 27% and 31% of baseline body weight, insulin requirement decreased from 0.6–0.95 to 0.3–0.83 IU/kg, and absolute reduction in HbA1c was 3–4%. Significant improvement in blood pressure, plasma lipid profile, and microalbuminuria was noted.
RYGB surgery in morbidly obese type 1 diabetes patients leads to a significant and maintained weight loss and results in remarkable improvement in blood glucose control and concomitant disorders. Bariatric surgery should be recommended to significantly obese type 1 diabetes patients as a means of reduction of vascular complications risk.
- Colquitt JL, Picot J, Loveman E, et al. Surgery for obesity. Cochrane Database Syst Rev. 2009;15:CD003641.
- Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122:248–56. CrossRef
- Czupryniak L, Strzelczyk J, Pawłowski M, et al. Mild elevation of fasting plasma glucose is a strong risk factor for postoperative complications in gastric bypass patients. Obes Surg. 2004;14:1393–7. CrossRef
- Alexandrides TK, Skroubis G, Kalfarentzos F. Resolution of diabetes mellitus and metabolic syndrome following Roux-en-Y gastric bypass and a variant of biliopancreatic diversion in patients with morbid obesity. Obes Surg. 2007;17:176–84. CrossRef
- Mechanick JI, Kushner RF, Sugerman HJ, et al. American Association of Clinical Endocrinologists; Obesity Society; American Society for Metabolic & Bariatric Surgery. American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery medical guidelines for clinical practice for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient. Obesity. 2009;17 Suppl 1:S1–70.
- de Boer IH, Kestenbaum B, Rue TC, et al. Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group. Insulin therapy, hyperglycemia, and hypertension in type 1 diabetes mellitus. Arch Intern Med. 2008;22:1867–73. CrossRef
- Pang TT, Narendran P. Addressing insulin resistance in type 1 diabetes. Diabet Med. 2008;25:1015–24. CrossRef
- Potenza MA, Gagliardi S, Nacci C, et al. Endothelial dysfunction in diabetes: from mechanisms to therapeutic targets. Curr Med Chem. 2009;16:94–112. CrossRef
- Bult MJ, van Dalen T, Muller AF. Surgical treatment of obesity. Eur J Endocrinol. 2008;158:135–45. CrossRef
- Meguid MM, Glade MJ, Middleton FA. Weight regain after Roux-en-Y: a significant 20% complication related to PYY. Nutrition. 2008;24:832–42. CrossRef
- Pinhas-Hamiel O, Zeitler P. The global spread of type 2 diabetes mellitus in children and adolescents. J Pediatr. 2005;146:693–700. CrossRef
- Liu LL, Lawrence JM, Davis C, et al. Prevalence of overweight and obesity in youth with diabetes in USA: the SEARCH for Diabetes in Youth Study. Pediatr Dia. 2009. doi:10.1111/j.1399-5448.2009.00519.x.
- Pozzilli P, Guglielmi C. Double diabetes: a mixture of type 1 and type 2 diabetes in youth. Endocr Dev. 2009;14:151–66. CrossRef
- Reinehr T, Schober E, Wiegand S, et al. Holl R; DPV-Wiss Study Group. Beta-cell autoantibodies in children with type 2 diabetes mellitus: subgroup or misclassification? Arch Dis Child. 2006;91:473–7. CrossRef
- Rosenbloom AL, Silverstein JH, Amemiya S, et al. ISPAD Clinical Practice Consensus Guidelines 2009 Compendium. Type 2 diabetes in the child and adolescent. Pediatric Dia. 2009;10 Suppl 12:17–32. CrossRef
- Long-Term Results of Gastric Bypass Surgery in Morbidly Obese Type 1 Diabetes Patients
Volume 20, Issue 4 , pp 506-508
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Type 1 diabetes
- Vascular complications
- Morbid obesity
- Gastric bypass
- Industry Sectors
- Author Affiliations
- 1. Diabetology and Metabolic Diseases Department, Barlicki University Hospital No 1, Kopcinskiego 22, 90-153, Lodz, Poland
- 2. General and Transplant Surgery Department, Barlicki University Hospital No 1, Medical University of Lodz, Lodz, Poland